Relx plc (REL)

Sector:

Media

Index:

FTSE 100

3,462.00p
   
  • Change Today:
      18.00p
  • 52 Week High: 3,504.00
  • 52 Week Low: 2,442.00
  • Currency: UK Pounds
  • Shares Issued: 1,873.78m
  • Volume: 2,278,641
  • Market Cap: £64,870m
  • RiskGrade: 128

Monday broker round-up

By Caoimhe Toman

Date: Monday 08 Oct 2018

LONDON (ShareCast) - (Sharecast News) - Mediclinic International: Investec upgrades to buy with a target price of 448p.
Pearson: Berenberg reiterates sell with a target price of 550p.

Astrazeneca: Deutsche Bank reiterates buy with a target price of 6,400p.

Glaxosmithkline: Deutsche Bank reiterates hold with a target price of 1,525p.

MONDI: Deutsche Bank reiterates buy with a target price of 2,600p.

WPP Group: Deutsche Bank reiterates hold with a target price of 1,430p.

Tullow Oil: Morgan Stanley reiterates overweight with a target price of 355p.

Brooks Macdonald: Numis downgrades to add with a target price of 2,210p.

UNITE Group: Numis reiterates hold with a target price of 900p.

Reach: Numis reiterates buy with a target price of 208p.

Rathbones: Numis upgrades to add with a target price of 2,730p.

Centamin: Numis reiterates buy with a target price of 130p.

Mitie: Canaccord reiterates buy with a target price of 300p.

Ferguson: Berenberg reiterates buy with a target price of 7,000p.

Johnson Matthey: Morgan Stanley reiterates overweight with a target price of 3,900p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Reed Elsevier Market Data

Currency UK Pounds
Share Price 3,462.00p
Change Today 18.00p
% Change 0.52 %
52 Week High 3,504.00
52 Week Low 2,442.00
Volume 2,278,641
Shares Issued 1,873.78m
Market Cap £64,870m
RiskGrade 128

Reed Elsevier Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
99.08% below the market average99.08% below the market average99.08% below the market average99.08% below the market average99.08% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
83.93% above the market average83.93% above the market average83.93% above the market average83.93% above the market average83.93% above the market average
91.49% above the sector average91.49% above the sector average91.49% above the sector average91.49% above the sector average91.49% above the sector average
Income
87.92% below the market average87.92% below the market average87.92% below the market average87.92% below the market average87.92% below the market average
80% below the sector average80% below the sector average80% below the sector average80% below the sector average80% below the sector average
Growth
13.98% below the market average13.98% below the market average13.98% below the market average13.98% below the market average13.98% below the market average
2.33% below the sector average2.33% below the sector average2.33% below the sector average2.33% below the sector average2.33% below the sector average

What The Brokers Say

Strong Buy 4
Buy 6
Neutral 5
Sell 0
Strong Sell 0
Total 15
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Reed Elsevier Dividends

  Latest Previous
  Final Interim
Ex-Div 02-May-24 03-Aug-23
Paid 13-Jun-24 07-Sep-23
Amount 41.80p 17.00p

Trades for 15-May-2024

Time Volume / Share Price
17:15 8,368 @ 3,476.73p
17:15 8,368 @ 3,477.78p
17:15 2,364 @ 3,476.73p
17:15 2,364 @ 3,477.78p
17:15 1,716 @ 3,476.73p

Reed Elsevier Key Personnel

CEO Erik Engstrom
CFO N L Luff
Chair Paul Walker

Top of Page